Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP807812.RA9EfuB_j8aGdfAgd6sfHdevxQ1VLhU8jL1LNijpUYikw130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP807812.RA9EfuB_j8aGdfAgd6sfHdevxQ1VLhU8jL1LNijpUYikw130_assertion type Assertion NP807812.RA9EfuB_j8aGdfAgd6sfHdevxQ1VLhU8jL1LNijpUYikw130_head.
- NP807812.RA9EfuB_j8aGdfAgd6sfHdevxQ1VLhU8jL1LNijpUYikw130_assertion description "[In addition, HMs that developed persistent disease displayed higher PAK1 immunoreactivity than those that regressed (P = 0.016), and elevated PAK1 immunoreactivity was observed in placental site trophoblastic tumors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP807812.RA9EfuB_j8aGdfAgd6sfHdevxQ1VLhU8jL1LNijpUYikw130_provenance.
- NP807812.RA9EfuB_j8aGdfAgd6sfHdevxQ1VLhU8jL1LNijpUYikw130_assertion evidence source_evidence_literature NP807812.RA9EfuB_j8aGdfAgd6sfHdevxQ1VLhU8jL1LNijpUYikw130_provenance.
- NP807812.RA9EfuB_j8aGdfAgd6sfHdevxQ1VLhU8jL1LNijpUYikw130_assertion SIO_000772 20413688 NP807812.RA9EfuB_j8aGdfAgd6sfHdevxQ1VLhU8jL1LNijpUYikw130_provenance.
- NP807812.RA9EfuB_j8aGdfAgd6sfHdevxQ1VLhU8jL1LNijpUYikw130_assertion wasDerivedFrom befree-2016 NP807812.RA9EfuB_j8aGdfAgd6sfHdevxQ1VLhU8jL1LNijpUYikw130_provenance.
- NP807812.RA9EfuB_j8aGdfAgd6sfHdevxQ1VLhU8jL1LNijpUYikw130_assertion wasGeneratedBy ECO_0000203 NP807812.RA9EfuB_j8aGdfAgd6sfHdevxQ1VLhU8jL1LNijpUYikw130_provenance.